2022
DOI: 10.1504/ijnt.2022.10052179
|View full text |Cite
|
Sign up to set email alerts
|

Bioanalytical method development and validation of a novel antiseizure agent Canobamate, using LC-MS/MS

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles